List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Pemetrexed Drug Product Introduction
1.2 Global Pemetrexed Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pemetrexed Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pemetrexed Drug Sales in Volume for the Year 2017-2028
1.3 United States Pemetrexed Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pemetrexed Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pemetrexed Drug Sales in Volume for the Year 2017-2028
1.4 Pemetrexed Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pemetrexed Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pemetrexed Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pemetrexed Drug Market Dynamics
1.5.1 Pemetrexed Drug Industry Trends
1.5.2 Pemetrexed Drug Market Drivers
1.5.3 Pemetrexed Drug Market Challenges
1.5.4 Pemetrexed Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pemetrexed Drug Market Segment by Type
2.1.1 100 mg lyophilized powder/vial
2.1.2 500 mg lyophilized powder/vial
2.2 Global Pemetrexed Drug Market Size by Type
2.2.1 Global Pemetrexed Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pemetrexed Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pemetrexed Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pemetrexed Drug Market Size by Type
2.3.1 United States Pemetrexed Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pemetrexed Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pemetrexed Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pemetrexed Drug Market Segment by Application
3.1.1 Pleural mesothelioma
3.1.2 Non-small cell lung cancer
3.2 Global Pemetrexed Drug Market Size by Application
3.2.1 Global Pemetrexed Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pemetrexed Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pemetrexed Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pemetrexed Drug Market Size by Application
3.3.1 United States Pemetrexed Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pemetrexed Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pemetrexed Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pemetrexed Drug Competitor Landscape by Company
4.1 Global Pemetrexed Drug Market Size by Company
4.1.1 Top Global Pemetrexed Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pemetrexed Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Pemetrexed Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Pemetrexed Drug Price by Manufacturer (2017-2022)
4.2 Global Pemetrexed Drug Concentration Ratio (CR)
4.2.1 Pemetrexed Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pemetrexed Drug in 2021
4.2.3 Global Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pemetrexed Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Pemetrexed Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pemetrexed Drug Product Type
4.3.3 Date of International Manufacturers Enter into Pemetrexed Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pemetrexed Drug Market Size by Company
4.5.1 Top Pemetrexed Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pemetrexed Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pemetrexed Drug Sales by Players (2020, 2021 & 2022)
5 Global Pemetrexed Drug Market Size by Region
5.1 Global Pemetrexed Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pemetrexed Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Pemetrexed Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Pemetrexed Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pemetrexed Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Pemetrexed Drug Sales in Value by Region: 2017-2022
5.3.2 Global Pemetrexed Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pemetrexed Drug Market Size YoY Growth 2017-2028
6.1.2 North America Pemetrexed Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pemetrexed Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pemetrexed Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pemetrexed Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Pemetrexed Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pemetrexed Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Pemetrexed Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pemetrexed Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pemetrexed Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporation Information
7.1.2 Eli Lilly and Company Description and Business Overview
7.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Eli Lilly and Company Pemetrexed Drug Products Offered
7.1.5 Eli Lilly and Company Recent Development
7.2 Pfizer
7.2.1 Pfizer Corporation Information
7.2.2 Pfizer Description and Business Overview
7.2.3 Pfizer Pemetrexed Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Pfizer Pemetrexed Drug Products Offered
7.2.5 Pfizer Recent Development
7.3 Teva
7.3.1 Teva Corporation Information
7.3.2 Teva Description and Business Overview
7.3.3 Teva Pemetrexed Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Teva Pemetrexed Drug Products Offered
7.3.5 Teva Recent Development
7.4 Eagle Pharmaceuticals
7.4.1 Eagle Pharmaceuticals Corporation Information
7.4.2 Eagle Pharmaceuticals Description and Business Overview
7.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eagle Pharmaceuticals Pemetrexed Drug Products Offered
7.4.5 Eagle Pharmaceuticals Recent Development
7.5 APOTEX
7.5.1 APOTEX Corporation Information
7.5.2 APOTEX Description and Business Overview
7.5.3 APOTEX Pemetrexed Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 APOTEX Pemetrexed Drug Products Offered
7.5.5 APOTEX Recent Development
7.6 Qilu Pharmaceutical
7.6.1 Qilu Pharmaceutical Corporation Information
7.6.2 Qilu Pharmaceutical Description and Business Overview
7.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Qilu Pharmaceutical Pemetrexed Drug Products Offered
7.6.5 Qilu Pharmaceutical Recent Development
7.7 Biocon
7.7.1 Biocon Corporation Information
7.7.2 Biocon Description and Business Overview
7.7.3 Biocon Pemetrexed Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Biocon Pemetrexed Drug Products Offered
7.7.5 Biocon Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pemetrexed Drug Industry Chain Analysis
8.2 Pemetrexed Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pemetrexed Drug Distributors
8.3 Pemetrexed Drug Production Mode & Process
8.4 Pemetrexed Drug Sales and Marketing
8.4.1 Pemetrexed Drug Sales Channels
8.4.2 Pemetrexed Drug Distributors
8.5 Pemetrexed Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
